<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The c-fms proto-oncogene product, which is the receptor for the macrophage colony-stimulating factor CSF-1, is always found expressed in <z:hpo ids='HP_0004808'>acute myeloid leukemia</z:hpo> cells, irrespective of their stage of differentiation according to the FAB classification (Dubreuil P, Torr√®s H, Courcoul M, Birg F, Mannoni P </plain></SENT>
<SENT sid="1" pm="."><plain>Blood 1988;72:1081-1085) </plain></SENT>
<SENT sid="2" pm="."><plain>We have extended this study and looked for c-fms expression in poorly differentiated myeloid <z:hpo ids='HP_0001909'>leukemias</z:hpo>, in a series of <z:hpo ids='HP_0002488'>acute leukemias</z:hpo> of either T or B origin and in biphenotypic <z:hpo ids='HP_0001909'>leukemias</z:hpo> </plain></SENT>
<SENT sid="3" pm="."><plain>We now report that expression of c-fms is still related to the myeloid origin of the leukemic proliferation, but that it can also be found in some <z:hpo ids='HP_0002488'>acute leukemias</z:hpo> presenting clonal rearrangements of the T cell receptor gene </plain></SENT>
<SENT sid="4" pm="."><plain>Thus expression of the c-fms/CSF-1 receptor may not be exclusively a marker for <z:e sem="disease" ids="C1513644" disease_type="Neoplastic Process" abbrv="">myeloid proliferations</z:e> </plain></SENT>
</text></document>